These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 23330258

  • 1. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O, Avni Y, Morgenstern S, Ben-Ari Z.
    Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
    [Abstract] [Full Text] [Related]

  • 2. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W, Marlicz W, Smereczyński A, Lawniczak M, Lewosiuk A, Starzyńska T.
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
    [Abstract] [Full Text] [Related]

  • 3. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E, Hanauer SB.
    J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
    [Abstract] [Full Text] [Related]

  • 4. [Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease].
    Laish I, Pomeranz I, Kitay-Cohen Y, Konikof F.
    Harefuah; 2012 Dec; 151(12):692-5, 720. PubMed ID: 23330262
    [Abstract] [Full Text] [Related]

  • 5. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
    Musumba CO.
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1025-37. PubMed ID: 24099468
    [Abstract] [Full Text] [Related]

  • 6. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L, Marko C, Breidert M.
    Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
    [Abstract] [Full Text] [Related]

  • 7. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C, de la Fuente-Fernández E, Corbatón P, Sánchez MC, Gisbert JP.
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [Abstract] [Full Text] [Related]

  • 8. Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia.
    De Boer NK, Tuynman H, Bloemena E, Westerga J, Van Der Peet DL, Mulder CJ, Cuesta MA, Meuwissen SG, Van Nieuwkerk CM, Van Bodegraven AA.
    Scand J Gastroenterol; 2008 Jan; 43(5):604-8. PubMed ID: 18415755
    [Abstract] [Full Text] [Related]

  • 9. A histopathologic pattern of centrilobular hepatocyte injury suggests 6-mercaptopurine-induced hepatotoxicity in patients with inflammatory bowel disease.
    Masia R, Pratt DS, Misdraji J.
    Arch Pathol Lab Med; 2012 Jun; 136(6):618-22. PubMed ID: 22646267
    [Abstract] [Full Text] [Related]

  • 10. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease.
    Tuyama AC, Krakauer M, Alzaabi M, Fiel MI, Legnani P, Schiano TD.
    J Crohns Colitis; 2013 Aug; 7(7):590-3. PubMed ID: 22841133
    [Abstract] [Full Text] [Related]

  • 11. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL, Miles CJ, Gearry RB.
    N Z Med J; 2010 Apr 30; 123(1313):74-6. PubMed ID: 20581898
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.
    Gilissen LPL, Tajzai R, Romberg M, Pierik M, Stronkhorst A, Steenhuisen K, Van Bodegraven A, Daniels A, Wong D.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e102-e107. PubMed ID: 33136726
    [Abstract] [Full Text] [Related]

  • 13. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine.
    Buster EH, van Vuuren HJ, Zondervan PE, Metselaar HJ, Tilanus HW, de Man RA.
    Eur J Gastroenterol Hepatol; 2008 Jan 01; 20(1):68-72. PubMed ID: 18090994
    [Abstract] [Full Text] [Related]

  • 14. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D, Decaestecker J, De Wulf D, Ghillebert G, Van Vlierberghe H, Van Dorpe J, Baert F.
    Acta Gastroenterol Belg; 2013 Sep 01; 76(3):342-6. PubMed ID: 24261031
    [Abstract] [Full Text] [Related]

  • 15. Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Seinen ML, van Asseldonk DP, de Boer NK, Bouma G, van Nieuwkerk CM, Mulder CJ, Bloemena E, van Bodegraven AA.
    Inflamm Bowel Dis; 2017 Mar 01; 23(3):448-452. PubMed ID: 28151736
    [Abstract] [Full Text] [Related]

  • 16. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK.
    Ther Drug Monit; 2015 Dec 01; 37(6):797-804. PubMed ID: 25853923
    [Abstract] [Full Text] [Related]

  • 17. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
    Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF.
    Gut; 2007 Oct 01; 56(10):1404-9. PubMed ID: 17504943
    [Abstract] [Full Text] [Related]

  • 18. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M, Preiss JC, Loddenkemper C, Günther U, Somasundaram R, Siegmund B, Zeitz M.
    Dtsch Med Wochenschr; 2008 Sep 01; 133(38):1897-900. PubMed ID: 18788068
    [Abstract] [Full Text] [Related]

  • 19. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP.
    Gastroenterol Hepatol; 2011 Sep 01; 34(6):385-92. PubMed ID: 21616565
    [Abstract] [Full Text] [Related]

  • 20. A rare cause of noncirrhotic intrahepatic portal hypertension.
    Chugh P, Park JS, Hajdu CH.
    Gastroenterology; 2014 Sep 01; 147(3):e7-9. PubMed ID: 25064548
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.